Overall, our work highlights the contribution of EMT in CD73 transcriptional regulation in TNBC cells and supports the concept of evaluating the relevance of combining inhibitors of the EMT process to improve CD73- and other immune checkpoints-based cancer immunotherapy. This evidence concerns the gene NT5E and cancer.